<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37108835</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Molecular and Physiological Determinants of Amyotrophic Lateral Sclerosis: What the DJ-1 Protein Teaches Us.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7674</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24087674</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult-onset disease which causes the progressive degeneration of cortical and spinal motoneurons, leading to death a few years after the first symptom onset. ALS is mainly a sporadic disorder, and its causative mechanisms are mostly unclear. About 5-10% of cases have a genetic inheritance, and the study of ALS-associated genes has been fundamental in defining the pathological pathways likely also involved in the sporadic forms of the disease. Mutations affecting the <i>DJ-1</i> gene appear to explain a subset of familial ALS forms. DJ-1 is involved in multiple molecular mechanisms, acting primarily as a protective agent against oxidative stress. Here, we focus on the involvement of DJ-1 in interconnected cellular functions related to mitochondrial homeostasis, reactive oxygen species (ROS) levels, energy metabolism, and hypoxia response, in both physiological and pathological conditions. We discuss the possibility that impairments in one of these pathways may affect the others, contributing to a pathological background in which additional environmental or genetic factors may act in favor of the onset and/or progression of ALS. These pathways may represent potential therapeutic targets to reduce the likelihood of developing ALS and/or slow disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sandrelli</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5631-7467</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisaglia</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3968-8418</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Study Center for Neurodegeneration (CESNE), 35100 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="D000071617">Protein Deglycase DJ-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071617" MajorTopicYN="N">Protein Deglycase DJ-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DJ-1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">hypoxia</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37108835</ArticleId><ArticleId IdType="pmc">PMC10144135</ArticleId><ArticleId IdType="doi">10.3390/ijms24087674</ArticleId><ArticleId IdType="pii">ijms24087674</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G.S.A., Antonyuk S.V., Hasnain S.S. The Biophysics of Superoxide Dismutase-1 and Amyotrophic Lateral Sclerosis. Q. Rev. Biophys. 2019;52:e12. doi: 10.1017/S003358351900012X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003358351900012X</ArticleId><ArticleId IdType="pubmed">31760962</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Hilton J.B., Hare D.J., Crouch P.J., Double K.L. Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic. Angew. Chem. Int. Ed. Engl. 2021;60:9215&#x2013;9246. doi: 10.1002/anie.202000451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202000451</ArticleId><ArticleId IdType="pmc">PMC8247289</ArticleId><ArticleId IdType="pubmed">32144830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton J.B., Mercer S.W., Lim N.K.H., Faux N.G., Buncic G., Beckman J.S., Roberts B.R., Donnelly P.S., White A.R., Crouch P.J. CuII(Atsm) Improves the Neurological Phenotype and Survival of SOD1G93A Mice and Selectively Increases Enzymatically Active SOD1 in the Spinal Cord. Sci. Rep. 2017;7:42292. doi: 10.1038/srep42292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42292</ArticleId><ArticleId IdType="pmc">PMC5304223</ArticleId><ArticleId IdType="pubmed">28205575</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.R., Trias E., Beilby P.R., Lopez N.I., Labut E.M., Bradford C.S., Roberts B.R., McAllum E.J., Crouch P.J., Rhoads T.W., et al. Copper Delivery to the CNS by CuATSM Effectively Treats Motor Neuron Disease in SOD(G93A) Mice Co-Expressing the Copper-Chaperone-for-SOD. Neurobiol. Dis. 2016;89:1&#x2013;9. doi: 10.1016/j.nbd.2016.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.01.020</ArticleId><ArticleId IdType="pmc">PMC4785045</ArticleId><ArticleId IdType="pubmed">26826269</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts B.R., Lim N.K.H., McAllum E.J., Donnelly P.S., Hare D.J., Doble P.A., Turner B.J., Price K.A., Lim S.C., Paterson B.M., et al. Oral Treatment with Cu(II)(Atsm) Increases Mutant SOD1 in Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. J. Neurosci. 2014;34:8021&#x2013;8031. doi: 10.1523/JNEUROSCI.4196-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4196-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist B.G., Genoud S., Roudeau S., Rookyard A., Abdeen A., Cottam V., Hare D.J., White M., Altvater J., Fifita J.A., et al. Altered SOD1 Maturation and Post-Translational Modification in Amyotrophic Lateral Sclerosis Spinal Cord. Brain. 2022;145:3108&#x2013;3130. doi: 10.1093/brain/awac165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac165</ArticleId><ArticleId IdType="pmc">PMC9473357</ArticleId><ArticleId IdType="pubmed">35512359</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP Mutations in Individuals with Sporadic and Familial Amyotrophic Lateral Sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M.C., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP Mutations in Amyotrophic Lateral Sclerosis with TDP-43 Neuropathology: A Genetic and Histopathological Analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar C., Salado I.G., De La Encarnaci&#xf3;n A., P&#xe9;rez D.I., Moreno F., Gil C., De Munain A.L., Mart&#xed;nez A., Mart&#xed;n-Requero &#xc1;. Targeting TDP-43 Phosphorylation by Casein Kinase-1&#x3b4; Inhibitors: A Novel Strategy for the Treatment of Frontotemporal Dementia. Mol. Neurodegener. 2016;11:36. doi: 10.1186/s13024-016-0102-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0102-7</ArticleId><ArticleId IdType="pmc">PMC4852436</ArticleId><ArticleId IdType="pubmed">27138926</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesi G., Savettieri G., Pugliese P., D&#x2019;Amelio M., Tarantino P., Ragonese P., La Bella V., Piccoli T., Civitelli D., Annesi F., et al. DJ-1 Mutations and Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex. Ann. Neurol. 2005;58:803&#x2013;807. doi: 10.1002/ana.20666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20666</ArticleId><ArticleId IdType="pubmed">16240358</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosa A., Sandrelli F., Beltramini M., Greggio E., Bubacco L., Bisaglia M. Recent Findings on the Physiological Function of DJ-1: Beyond Parkinson&#x2019;s Disease. Neurobiol. Dis. 2017;108:65&#x2013;72. doi: 10.1016/j.nbd.2017.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.08.005</ArticleId><ArticleId IdType="pubmed">28823929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanagasi H.A., Giri A., Kartal E., Guven G., Bilgi&#xe7; B., Hauser A.K., Emre M., Heutink P., Basak N., Gasser T., et al. A Novel Homozygous DJ1 Mutation Causes Parkinsonism and ALS in a Turkish Family. Park. Relat. Disord. 2016;29:117&#x2013;120. doi: 10.1016/j.parkreldis.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2016.03.001</ArticleId><ArticleId IdType="pubmed">26972524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S., Mori A., Kimura E., Mita S., Maeda Y., Hirano T., Uchino M. DJ-1 Forms Complexes with Mutant SOD1 and Ameliorates Its Toxicity. J. Neurochem. 2010;113:860&#x2013;870. doi: 10.1111/j.1471-4159.2010.06658.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06658.x</ArticleId><ArticleId IdType="pubmed">20202083</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S., Sipos J., Thau-Habermann N., K&#xf6;rner S., Rath K.J., Dengler R., Petri S. Altered Expression of DJ-1 and PINK1 in Sporadic ALS and in the SOD1(G93A) ALS Mouse Model. J. Neuropathol. Exp. Neurol. 2013;72:1052&#x2013;1061. doi: 10.1097/NEN.0000000000000004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000004</ArticleId><ArticleId IdType="pubmed">24128678</ArticleId></ArticleIdList></Reference><Reference><Citation>Lev N., Barhum Y., Lotan I., Steiner I., Offen D. DJ-1 Knockout Augments Disease Severity and Shortens Survival in a Mouse Model of ALS. PLoS ONE. 2015;10:e0117190. doi: 10.1371/journal.pone.0117190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0117190</ArticleId><ArticleId IdType="pmc">PMC4379040</ArticleId><ArticleId IdType="pubmed">25822630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Zhang Z.F., Lei R.X., Wang S., Zhuang Y., Liu A.C., Wu Y., Chen J., Tang J.C., Pan M.X., et al. DJ-1 Suppresses Cytoplasmic TDP-43 Aggregation in Oxidative Stress-Induced Cell Injury. J. Alzheimers Dis. 2018;66:1001&#x2013;1014. doi: 10.3233/JAD-180460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180460</ArticleId><ArticleId IdType="pubmed">30372676</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Hendrix S., Berry J.D., Elliott M.A., Maiser S., Karam C., Caress J.B., Owegi M.A., Quick A., et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2020;383:919&#x2013;930. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Bercury K., Cummiskey J., Luong N., Lebin J., Freed C.R. Phenylbutyrate Up-Regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease. J. Biol. Chem. 2011;286:14941&#x2013;14951. doi: 10.1074/jbc.M110.211029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.211029</ArticleId><ArticleId IdType="pmc">PMC3083206</ArticleId><ArticleId IdType="pubmed">21372141</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.X., Lei J., Wang B.D., Feng D.Y., Huang L., Li Y.Q., Li T., Zhu G., Li C., Lu F.F., et al. Pretreatment with Sodium Phenylbutyrate Alleviates Cerebral Ischemia/Reperfusion Injury by Upregulating DJ-1 Protein. Front. Neurol. 2017;8:256. doi: 10.3389/fneur.2017.00256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00256</ArticleId><ArticleId IdType="pmc">PMC5465296</ArticleId><ArticleId IdType="pubmed">28649223</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth H.D.E., Hirst W.D., Wade-Martins R. The Role of Astrocyte Dysfunction in Parkinson&#x2019;s Disease Pathogenesis. Trends Neurosci. 2017;40:358&#x2013;370. doi: 10.1016/j.tins.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC5462417</ArticleId><ArticleId IdType="pubmed">28527591</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Harten A.C.M., Phatnani H., Przedborski S. Non-Cell-Autonomous Pathogenic Mechanisms in Amyotrophic Lateral Sclerosis. Trends Neurosci. 2021;44:658&#x2013;668. doi: 10.1016/j.tins.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8972039</ArticleId><ArticleId IdType="pubmed">34006386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mencke P., Boussaad I., Romano C.D., Kitami T., Linster C.L., Kr&#xfc;ger R. The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson&#x2019;s Disease. Cells. 2021;10:347. doi: 10.3390/cells10020347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020347</ArticleId><ArticleId IdType="pmc">PMC7915027</ArticleId><ArticleId IdType="pubmed">33562311</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lazzari F., Bisaglia M. DJ-1 as a Deglycating Enzyme: A Unique Function to Explain a Multifaceted Protein? Neural Regen. Res. 2017;12:1797&#x2013;1798. doi: 10.4103/1673-5374.219035.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.219035</ArticleId><ArticleId IdType="pmc">PMC5745827</ArticleId><ArticleId IdType="pubmed">29239319</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lazzari F., Prag H.A., Gruszczyk A.V., Whitworth A.J., Bisaglia M. DJ-1: A Promising Therapeutic Candidate for Ischemia-Reperfusion Injury. Redox Biol. 2021;41:101884. doi: 10.1016/j.redox.2021.101884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101884</ArticleId><ArticleId IdType="pmc">PMC7872972</ArticleId><ArticleId IdType="pubmed">33561740</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lazzari F., Agostini F., Plotegher N., Sandre M., Greggio E., Megighian A., Bubacco L., Sandrelli F., Whitworth A.J., Bisaglia M. DJ-1 Promotes Energy Balance by Regulating Both Mitochondrial and Autophagic Homeostasis. Neurobiol. Dis. 2023;176:105941. doi: 10.1016/j.nbd.2022.105941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105941</ArticleId><ArticleId IdType="pubmed">36473592</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lazzari F., Agostini F., Doni D., Malacrida S., Zordan M.A., Costantini P., Bubacco L., Sandrelli F., Bisaglia M. DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila Melanogaster. Antioxidants. 2022;11:1527. doi: 10.3390/antiox11081527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11081527</ArticleId><ArticleId IdType="pmc">PMC9405364</ArticleId><ArticleId IdType="pubmed">36009245</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthukumaran K., Smith J., Jasra H., Sikorska M., Sandhu J.K., Cohen J., Lopatin D., Pandey S. Genetic Susceptibility Model of Parkinson&#x2019;s Disease Resulting from Exposure of DJ-1 Deficient Mice to MPTP: Evaluation of Neuroprotection by Ubisol-Q10. J. Parkinsons Dis. 2014;4:523&#x2013;530. doi: 10.3233/JPD-140368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-140368</ArticleId><ArticleId IdType="pubmed">25061060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavara-Culebras E., Paricio N. Drosophila DJ-1 Mutants Are Sensitive to Oxidative Stress and Show Reduced Lifespan and Motor Deficits. Gene. 2007;400:158&#x2013;165. doi: 10.1016/j.gene.2007.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2007.06.013</ArticleId><ArticleId IdType="pubmed">17651920</ArticleId></ArticleIdList></Reference><Reference><Citation>Meulener M., Whitworth A.J., Armstrong-Gold C.E., Rizzu P., Heutink P., Wes P.D., Pallanck L.J., Bonini N.M. Drosophila DJ-1 Mutants Are Selectively Sensitive to Environmental Toxins Associated with Parkinson&#x2019;s Disease. Curr. Biol. 2005;15:1572&#x2013;1577. doi: 10.1016/j.cub.2005.07.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.07.064</ArticleId><ArticleId IdType="pubmed">16139213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., et al. Hypersensitivity of DJ-1-Deficient Mice to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyrindine (MPTP) and Oxidative Stress. Proc. Natl. Acad. Sci. USA. 2005;102:5215&#x2013;5220. doi: 10.1073/pnas.0501282102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501282102</ArticleId><ArticleId IdType="pmc">PMC555037</ArticleId><ArticleId IdType="pubmed">15784737</ArticleId></ArticleIdList></Reference><Reference><Citation>Batelli S., Invernizzi R.W., Negro A., Calcagno E., Rodilossi S., Forloni G., Albani D. The Parkinson&#x2019;s Disease-Related Protein DJ-1 Protects Dopaminergic Neurons in Vivo and Cultured Cells from Alpha-Synuclein and 6-Hydroxydopamine Toxicity. Neurodegener. Dis. 2015;15:13&#x2013;23. doi: 10.1159/000367993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000367993</ArticleId><ArticleId IdType="pubmed">25500798</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinat C., Shendelman S., Jonason A., Leete T., Beal M.F., Yang L., Floss T., Abeliovich A. Sensitivity to Oxidative Stress in DJ-1-Deficient Dopamine Neurons: An ES- Derived Cell Model of Primary Parkinsonism. PLoS Biol. 2004;2:e327. doi: 10.1371/journal.pbio.0020327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0020327</ArticleId><ArticleId IdType="pmc">PMC521171</ArticleId><ArticleId IdType="pubmed">15502868</ArticleId></ArticleIdList></Reference><Reference><Citation>Taira T., Saito Y., Niki T., Iguchi-Ariga S.M.M., Takahashi K., Ariga H. DJ-1 Has a Role in Antioxidative Stress to Prevent Cell Death. EMBO Rep. 2004;5:213&#x2013;218. doi: 10.1038/sj.embor.7400074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400074</ArticleId><ArticleId IdType="pmc">PMC1298985</ArticleId><ArticleId IdType="pubmed">14749723</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson M.A. The Role of Cysteine Oxidation in DJ-1 Function and Dysfunction. Antioxid. Redox Signal. 2011;15:111&#x2013;122. doi: 10.1089/ars.2010.3481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3481</ArticleId><ArticleId IdType="pmc">PMC3110098</ArticleId><ArticleId IdType="pubmed">20812780</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M., Chen S. DJ-1 in Neurodegenerative Diseases: Pathogenesis and Clinical Application. Prog. Neurobiol. 2021;204:102114. doi: 10.1016/j.pneurobio.2021.102114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2021.102114</ArticleId><ArticleId IdType="pubmed">34174373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Liu J., Chen S., Wang Y., Cao L., Zhang Y., Kang W., Li H., Gui Y., Chen S., et al. DJ-1 Modulates the Expression of Cu/Zn-Superoxide Dismutase-1 through the Erk1/2-Elk1 Pathway in Neuroprotection. Ann. Neurol. 2011;70:591&#x2013;599. doi: 10.1002/ana.22514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22514</ArticleId><ArticleId IdType="pubmed">21796667</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y.F., Yang W.J., Xu Q., Chen H.P., Huang X.S., Qiu L.Y., Liao Z.P., Huang Q.R. DJ-1 Upregulates Anti-Oxidant Enzymes and Attenuates Hypoxia/Re-Oxygenation-Induced Oxidative Stress by Activation of the Nuclear Factor Erythroid 2-like 2 Signaling Pathway. Mol. Med. Rep. 2015;12:4734&#x2013;4742. doi: 10.3892/mmr.2015.3947.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2015.3947</ArticleId><ArticleId IdType="pubmed">26081287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y.F., Chen H.P., Huang X.S., Qiu L.Y., Liao Z.P., Huang Q.R. DJ-1 Mediates the Delayed Cardioprotection of Hypoxic Preconditioning Through Activation of Nrf2 and Subsequent Upregulation of Antioxidative Enzymes. J. Cardiovasc. Pharmacol. 2015;66:148&#x2013;158. doi: 10.1097/FJC.0000000000000257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000257</ArticleId><ArticleId IdType="pubmed">25915512</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements C.M., McNally R.S., Conti B.J., Mak T.W., Ting J.P.Y. DJ-1, a Cancer- and Parkinson&#x2019;s Disease-Associated Protein, Stabilizes the Antioxidant Transcriptional Master Regulator Nrf2. Proc. Natl. Acad. Sci. USA. 2006;103:15091&#x2013;15096. doi: 10.1073/pnas.0607260103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607260103</ArticleId><ArticleId IdType="pmc">PMC1586179</ArticleId><ArticleId IdType="pubmed">17015834</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslanbaeva L., Bisaglia M. Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment. Molecules. 2022;27:1471. doi: 10.3390/molecules27051471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27051471</ArticleId><ArticleId IdType="pmc">PMC8911691</ArticleId><ArticleId IdType="pubmed">35268572</ArticleId></ArticleIdList></Reference><Reference><Citation>Boas S.M., Joyce K.L., Cowell R.M. The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention. Antioxidants. 2021;11:8. doi: 10.3390/antiox11010008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010008</ArticleId><ArticleId IdType="pmc">PMC8772787</ArticleId><ArticleId IdType="pubmed">35052512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bono S., Feligioni M., Corbo M. Impaired Antioxidant KEAP1-NRF2 System in Amyotrophic Lateral Sclerosis: NRF2 Activation as a Potential Therapeutic Strategy. Mol. Neurodegener. 2021;16:71. doi: 10.1186/s13024-021-00479-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00479-8</ArticleId><ArticleId IdType="pmc">PMC8521937</ArticleId><ArticleId IdType="pubmed">34663413</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Villegas J., Ferraiuolo L., Mead R.J., Shaw P.J., Cuadrado A., Rojo A.I. NRF2 as a Therapeutic Opportunity to Impact in the Molecular Roadmap of ALS. Free Radic. Biol. Med. 2021;173:125&#x2013;141. doi: 10.1016/j.freeradbiomed.2021.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.07.022</ArticleId><ArticleId IdType="pubmed">34314817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkblom B., Adilbayeva A., Maple-Gr&#xf8;dem J., Piston D., &#xd6;kvist M., Xu X.M., Brede C., Larsen J.P., M&#xf8;ller S.G. Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-Induced Cytotoxicity. J. Biol. Chem. 2013;288:22809&#x2013;22820. doi: 10.1074/jbc.M113.482091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.482091</ArticleId><ArticleId IdType="pmc">PMC3829365</ArticleId><ArticleId IdType="pubmed">23792957</ArticleId></ArticleIdList></Reference><Reference><Citation>Puno M.R., Patel N.A., M&#xf8;ller S.G., Robinson C.V., Moody P.C.E., Odell M. Structure of Cu(I)-Bound DJ-1 Reveals a Biscysteinate Metal Binding Site at the Homodimer Interface: Insights into Mutational Inactivation of DJ-1 in Parkinsonism. J. Am. Chem. Soc. 2013;135:15974&#x2013;15977. doi: 10.1021/ja406010m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja406010m</ArticleId><ArticleId IdType="pubmed">24144264</ArticleId></ArticleIdList></Reference><Reference><Citation>Girotto S., Cendron L., Bisaglia M., Tessari I., Mammi S., Zanotti G., Bubacco L. DJ-1 Is a Copper Chaperone Acting on SOD1 Activation. J. Biol. Chem. 2014;289:10887&#x2013;10899. doi: 10.1074/jbc.M113.535112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.535112</ArticleId><ArticleId IdType="pmc">PMC4036200</ArticleId><ArticleId IdType="pubmed">24567322</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X.M., Lin H., Maple J., Bj&#xf6;rkblom B., Alves G., Larsen J.P., M&#xf8;ller S.G. The Arabidopsis DJ-1a Protein Confers Stress Protection through Cytosolic SOD Activation. J. Cell Sci. 2010;123:1644&#x2013;1651. doi: 10.1242/jcs.063222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.063222</ArticleId><ArticleId IdType="pubmed">20406884</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri L., Luchinat E., Banci L. Intracellular Metal Binding and Redox Behavior of Human DJ-1. J. Biol. Inorg. Chem. 2018;23:61&#x2013;69. doi: 10.1007/s00775-017-1509-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00775-017-1509-5</ArticleId><ArticleId IdType="pubmed">29218631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottolini D., Cal&#xec; T., Negro A., Brini M. The Parkinson Disease-Related Protein DJ-1 Counteracts Mitochondrial Impairment Induced by the Tumour Suppressor Protein P53 by Enhancing Endoplasmic Reticulum-Mitochondria Tethering. Hum. Mol. Genet. 2013;22:2152&#x2013;2168. doi: 10.1093/hmg/ddt068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt068</ArticleId><ArticleId IdType="pubmed">23418303</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J.Y., Park J.H., Kim S.J., Seo K.S., Han J.S., Lee S.H., Kim J.M., Park J.I., Park S.K., Lim K., et al. DJ-1 Null Dopaminergic Neuronal Cells Exhibit Defects in Mitochondrial Function and Structure: Involvement of Mitochondrial Complex I Assembly. PLoS ONE. 2012;7:e32629. doi: 10.1371/journal.pone.0032629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032629</ArticleId><ArticleId IdType="pmc">PMC3293835</ArticleId><ArticleId IdType="pubmed">22403686</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas K.J., McCoy M.K., Blackinton J., Beilina A., van der Brug M., Sandebring A., Miller D., Maric D., Cedazo-Minguez A., Cookson M.R. DJ-1 Acts in Parallel to the PINK1/Parkin Pathway to Control Mitochondrial Function and Autophagy. Hum. Mol. Genet. 2011;20:40&#x2013;50. doi: 10.1093/hmg/ddq430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq430</ArticleId><ArticleId IdType="pmc">PMC3000675</ArticleId><ArticleId IdType="pubmed">20940149</ArticleId></ArticleIdList></Reference><Reference><Citation>Irrcher I., Aleyasin H., Seifert E.L., Hewitt S.J., Chhabra S., Phillips M., Lutz A.K., Rousseaux M.W.C., Bevilacqua L., Jahani-Asl A., et al. Loss of the Parkinson&#x2019;s Disease-Linked Gene DJ-1 Perturbs Mitochondrial Dynamics. Hum. Mol. Genet. 2010;19:3734&#x2013;3746. doi: 10.1093/hmg/ddq288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq288</ArticleId><ArticleId IdType="pubmed">20639397</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebiehl G., Ruckerbauer S., Burbulla L.F., Kieper N., Maurer B., Waak J., Wolburg H., Gizatullina Z., Gellerich F.N., Woitalla D., et al. Reduced Basal Autophagy and Impaired Mitochondrial Dynamics Due to Loss of Parkinson&#x2019;s Disease-Associated Protein DJ-1. PLoS ONE. 2010;5:e9367. doi: 10.1371/journal.pone.0009367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009367</ArticleId><ArticleId IdType="pmc">PMC2826413</ArticleId><ArticleId IdType="pubmed">20186336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser D.N., Primiani C.T., Cookson M.R. The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for Their Pathogenicity. Curr. Protein Pept. Sci. 2017;18:702&#x2013;714. doi: 10.2174/1389203717666160311121954.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203717666160311121954</ArticleId><ArticleId IdType="pmc">PMC5140758</ArticleId><ArticleId IdType="pubmed">26965687</ArticleId></ArticleIdList></Reference><Reference><Citation>Imberechts D., Kinnart I., Wauters F., Terbeek J., Manders L., Wierda K., Eggermont K., Madeiro R.F., Sue C., Verfaillie C., et al. DJ-1 Is an Essential Downstream Mediator in PINK1/Parkin-Dependent Mitophagy. Brain. 2022;145:4368&#x2013;4384. doi: 10.1093/brain/awac313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac313</ArticleId><ArticleId IdType="pmc">PMC9762950</ArticleId><ArticleId IdType="pubmed">36039535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa K., Tsumoto H., Miura Y., Yamaguchi J., Iguchi-Ariga S.M.M., Sakuma T., Yamamoto T., Uchiyama Y. DJ-1 Is Indispensable for the S-Nitrosylation of Parkin, Which Maintains Function of Mitochondria. Sci. Rep. 2020;10:4377. doi: 10.1038/s41598-020-61287-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61287-6</ArticleId><ArticleId IdType="pmc">PMC7062835</ArticleId><ArticleId IdType="pubmed">32152416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L.Y., Giasson B.I., Bonini N.M. DJ-1 Is Critical for Mitochondrial Function and Rescues PINK1 Loss of Function. Proc. Natl. Acad. Sci. USA. 2010;107:9747&#x2013;9752. doi: 10.1073/pnas.0911175107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911175107</ArticleId><ArticleId IdType="pmc">PMC2906840</ArticleId><ArticleId IdType="pubmed">20457924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cal&#xec; T., Ottolini D., Soriano M.E., Brini M. A New Split-GFP-Based Probe Reveals DJ-1 Translocation into the Mitochondrial Matrix to Sustain ATP Synthesis upon Nutrient Deprivation. Hum. Mol. Genet. 2015;24:1045&#x2013;1060. doi: 10.1093/hmg/ddu519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu519</ArticleId><ArticleId IdType="pubmed">25305074</ArticleId></ArticleIdList></Reference><Reference><Citation>Junn E., Jang W.H., Zhao X., Jeong B.S., Mouradian M.M. Mitochondrial Localization of DJ-1 Leads to Enhanced Neuroprotection. J. Neurosci. Res. 2009;87:123&#x2013;129. doi: 10.1002/jnr.21831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21831</ArticleId><ArticleId IdType="pmc">PMC2752655</ArticleId><ArticleId IdType="pubmed">18711745</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet-Avil&#xe9;s R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R. The Parkinson&#x2019;s Disease Protein DJ-1 Is Neuroprotective Due to Cysteine-Sulfinic Acid-Driven Mitochondrial Localization. Proc. Natl. Acad. Sci. USA. 2004;101:9103&#x2013;9108. doi: 10.1073/pnas.0402959101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402959101</ArticleId><ArticleId IdType="pmc">PMC428480</ArticleId><ArticleId IdType="pubmed">15181200</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares P., Silva C., Chavarria D., Silva F.S.G., Oliveira P.J., Borges F. Drug Discovery and Amyotrophic Lateral Sclerosis: Emerging Challenges and Therapeutic Opportunities. Ageing Res. Rev. 2023;83:101790. doi: 10.1016/j.arr.2022.101790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101790</ArticleId><ArticleId IdType="pubmed">36402404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Wang X., Huo Z., Chen Y., Liu J., Zhao Z., Meng F., Su Q., Bao W., Zhang L., et al. The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Cells. 2022;11:2049. doi: 10.3390/cells11132049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11132049</ArticleId><ArticleId IdType="pmc">PMC9265651</ArticleId><ArticleId IdType="pubmed">35805131</ArticleId></ArticleIdList></Reference><Reference><Citation>Solana-Manrique C., Sanz F.J., Ripoll&#xe9;s E., Ba&#xf1;&#xf3; M.C., Torres J., Mu&#xf1;oz-Soriano V., Paricio N. Enhanced Activity of Glycolytic Enzymes in Drosophila and Human Cell Models of Parkinson&#x2019;s Disease Based on DJ-1 Deficiency. Free Radic. Biol. Med. 2020;158:137&#x2013;148. doi: 10.1016/j.freeradbiomed.2020.06.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.06.036</ArticleId><ArticleId IdType="pubmed">32726690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser D.N., Mamais A., Conti M.M., Primiani C.T., Kumaran R., Dillman A.A., Langston R.G., Beilina A., Garcia J.H., Diaz-Ruiz A., et al. Hexokinases Link DJ-1 to the PINK1/Parkin Pathway. Mol. Neurodegener. 2017;12:70. doi: 10.1186/s13024-017-0212-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0212-x</ArticleId><ArticleId IdType="pmc">PMC5622528</ArticleId><ArticleId IdType="pubmed">28962651</ArticleId></ArticleIdList></Reference><Reference><Citation>Requejo-Aguilar R., Lopez-Fabuel I., Jimenez-Blasco D., Fernandez E., Almeida A., Bola&#xf1;os J.P. DJ1 Represses Glycolysis and Cell Proliferation by Transcriptionally Up-Regulating Pink1. Biochem. J. 2015;467:303&#x2013;310. doi: 10.1042/BJ20141025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20141025</ArticleId><ArticleId IdType="pmc">PMC4385472</ArticleId><ArticleId IdType="pubmed">25670069</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Wu H., Li M., Wen Y., Yu C., Xia L., Xia Q., Kong X. DJ-1 Deficiency Protects Hepatic Steatosis by Enhancing Fatty Acid Oxidation in Mice. Int. J. Biol. Sci. 2018;14:1892&#x2013;1900. doi: 10.7150/ijbs.28620.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.28620</ArticleId><ArticleId IdType="pmc">PMC6231226</ArticleId><ArticleId IdType="pubmed">30443192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R., Liu X.M., Sun J.G., Chen H., Ma J., Dong M., Peng S., Wang J.Q., Ding J.Q., Li D.H., et al. DJ-1 Maintains Energy and Glucose Homeostasis by Regulating the Function of Brown Adipose Tissue. Cell Discov. 2017;3:16054. doi: 10.1038/celldisc.2016.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/celldisc.2016.54</ArticleId><ArticleId IdType="pmc">PMC5309696</ArticleId><ArticleId IdType="pubmed">28224045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.M., Jang H.J., Choi S.Y., Park S.A., Kim I.S., Yang Y.R., Lee Y.H., Ryu S.H., Suh P.G. DJ-1 Contributes to Adipogenesis and Obesity-Induced Inflammation. Sci. Rep. 2014;4:4805. doi: 10.1038/srep04805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep04805</ArticleId><ArticleId IdType="pmc">PMC4055892</ArticleId><ArticleId IdType="pubmed">24925581</ArticleId></ArticleIdList></Reference><Reference><Citation>Solana-Manrique C., Sanz F.J., Torregrosa I., Palomino-Sch&#xe4;tzlein M., Hern&#xe1;ndez-Oliver C., Pineda-Lucena A., Paricio N. Metabolic Alterations in a Drosophila Model of Parkinson&#x2019;s Disease Based on DJ-1 Deficiency. Cells. 2022;11:331. doi: 10.3390/cells11030331.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030331</ArticleId><ArticleId IdType="pmc">PMC8834223</ArticleId><ArticleId IdType="pubmed">35159141</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanweert F., Schrauwen P., Phielix E. Role of Branched-Chain Amino Acid Metabolism in the Pathogenesis of Obesity and Type 2 Diabetes-Related Metabolic Disturbances BCAA Metabolism in Type 2 Diabetes. Nutr. Diabetes. 2022;12:35. doi: 10.1038/s41387-022-00213-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-022-00213-3</ArticleId><ArticleId IdType="pmc">PMC9356071</ArticleId><ArticleId IdType="pubmed">35931683</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillot S.J., Bolborea M., Dupuis L. Dysregulation of Energy Homeostasis in Amyotrophic Lateral Sclerosis. Curr. Opin. Neurol. 2021;34:773&#x2013;780. doi: 10.1097/WCO.0000000000000982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000982</ArticleId><ArticleId IdType="pubmed">34343139</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Li R., Kirk S.E., Tefera T.W., Xie T.Y., Tracey T.J., Kelk D., Wimberger E., Garton F.C., Roberts L., et al. Altered Skeletal Muscle Glucose-Fatty Acid Flux in Amyotrophic Lateral Sclerosis. Brain Commun. 2020;2:fcaa154. doi: 10.1093/BRAINCOMMS/FCAA154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BRAINCOMMS/FCAA154</ArticleId><ArticleId IdType="pmc">PMC7677608</ArticleId><ArticleId IdType="pubmed">33241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Szelechowski M., Amoedo N., Obre E., L&#xe9;ger C., Allard L., Bonneu M., Claverol S., Lacombe D., Oliet S., Chevallier S., et al. Metabolic Reprogramming in Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:3953. doi: 10.1038/s41598-018-22318-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22318-5</ArticleId><ArticleId IdType="pmc">PMC5834494</ArticleId><ArticleId IdType="pubmed">29500423</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R., Allen S.P., Goodall E.F., Kramer S., Ponger L.L., Heath P.R., Milo M., Hollinger H.C., Walsh T., Highley J.R., et al. Gene Expression Signatures in Motor Neurone Disease Fibroblasts Reveal Dysregulation of Metabolism, Hypoxia-Response and RNA Processing Functions. Neuropathol. Appl. Neurobiol. 2015;41:201&#x2013;226. doi: 10.1111/nan.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer C.W., Torrisi A., Pantelidou M., Santama N., Cavallaro S. Pathways and Genes Differentially Expressed in the Motor Cortex of Patients with Sporadic Amyotrophic Lateral Sclerosis. BMC Genom. 2007;8:26. doi: 10.1186/1471-2164-8-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-8-26</ArticleId><ArticleId IdType="pmc">PMC1796866</ArticleId><ArticleId IdType="pubmed">17244347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Ren&#xe9; F., Gonzalez De Aguilar J.L., Loeffler J.P. Evidence for Defective Energy Homeostasis in Amyotrophic Lateral Sclerosis: Benefit of a High-Energy Diet in a Transgenic Mouse Model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan K.S., Halang L., Woods I., Prehn J.H.M. A High-Fat Jelly Diet Restores Bioenergetic Balance and Extends Lifespan in the Presence of Motor Dysfunction and Lumbar Spinal Cord Motor Neuron Loss in TDP-43A315T Mutant C57BL6/J Mice. Dis. Model. Mech. 2016;9:1029&#x2013;1037. doi: 10.1242/dmm.024786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.024786</ArticleId><ArticleId IdType="pmc">PMC5047697</ArticleId><ArticleId IdType="pubmed">27491077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills A.M., Hubbard J., Macklin E.A., Glass J., Tandan R., Simpson E.P., Brooks B., Gelinas D., Mitsumoto H., Mozaffar T., et al. Hypercaloric Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Trial. Lancet. 2014;383:2065&#x2013;2072. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A.C., Dorst J., Dreyhaupt J., Weishaupt J.H., Kassubek J., Weiland U., Meyer T., Petri S., Hermann A., Emmer A., et al. Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2020;87:206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Lange D.J., Voustianiouk A., MacGrogan D., Ho L., Suh J., Humala N., Thiyagarajan M., Wang J., Pasinetti G.M. A Ketogenic Diet as a Potential Novel Therapeutic Intervention in Amyotrophic Lateral Sclerosis. BMC Neurosci. 2006;7:29. doi: 10.1186/1471-2202-7-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-7-29</ArticleId><ArticleId IdType="pmc">PMC1488864</ArticleId><ArticleId IdType="pubmed">16584562</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., O&#x2019;Conner A.G., Barrows J.M., Shreiner D.D., Birchak G.J., Zarnescu D.C. Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. Front. Mol. Neurosci. 2018;11:182. doi: 10.3389/fnmol.2018.00182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00182</ArticleId><ArticleId IdType="pmc">PMC5990617</ArticleId><ArticleId IdType="pubmed">29904341</ArticleId></ArticleIdList></Reference><Reference><Citation>Han R., Liang J., Zhou B. Glucose Metabolic Dysfunction in Neurodegenerative Diseases-New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming. Int. J. Mol. Sci. 2021;22:5887. doi: 10.3390/ijms22115887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115887</ArticleId><ArticleId IdType="pmc">PMC8198281</ArticleId><ArticleId IdType="pubmed">34072616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tello D., Balsa E., Acosta-Iborra B., Fuertes-Yebra E., Elorza A., Ord&#xf3;&#xf1;ez &#xc1;., Corral-Escariz M., Soro I., L&#xf3;pez-Bernardo E., Perales-Clemente E., et al. Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1&#x3b1; Decreases Oxygen Consumption by Inhibiting Complex I Activity. Cell Metab. 2011;14:768&#x2013;779. doi: 10.1016/j.cmet.2011.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.10.008</ArticleId><ArticleId IdType="pubmed">22100406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Xue Y., Li Y., Gao S., Peng L., Zhao Y., Yu S. DJ-1 Protein Inhibits Apoptosis in Cerebral Ischemia by Regulating the Notch1 and Nuclear Factor Erythroid2-Related Factor 2 Signaling Pathways. Neuroscience. 2022;504:33&#x2013;46. doi: 10.1016/j.neuroscience.2022.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2022.09.016</ArticleId><ArticleId IdType="pubmed">36167256</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L., Zhao Y., Li Y., Zhou Y., Li L., Lei S., Yu S., Zhao Y. Effect of DJ-1 on the Neuroprotection of Astrocytes Subjected to Cerebral Ischemia/Reperfusion Injury. J. Mol. Med. 2019;97:189&#x2013;199. doi: 10.1007/s00109-018-1719-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-018-1719-5</ArticleId><ArticleId IdType="pmc">PMC6348070</ArticleId><ArticleId IdType="pubmed">30506316</ArticleId></ArticleIdList></Reference><Reference><Citation>Molcho L., Ben-Zur T., Barhum Y., Offen D. DJ-1 Based Peptide, ND-13, Promote Functional Recovery in Mouse Model of Focal Ischemic Injury. PLoS ONE. 2018;13:e0192954. doi: 10.1371/journal.pone.0192954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192954</ArticleId><ArticleId IdType="pmc">PMC5831040</ArticleId><ArticleId IdType="pubmed">29489843</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleyasin H., Rousseaux M.W.C., Phillips M., Kim R.H., Bland R.J., Callaghan S., Slack R.S., During M.J., Mak T.W., Park D.S. The Parkinson&#x2019;s Disease Gene DJ-1 Is Also a Key Regulator of Stroke-Induced Damage. Proc. Natl. Acad. Sci. USA. 2007;104:18748&#x2013;18753. doi: 10.1073/pnas.0709379104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0709379104</ArticleId><ArticleId IdType="pmc">PMC2141848</ArticleId><ArticleId IdType="pubmed">18003894</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu Y., Lambert J.P., Nicholson C.K., Kim J.J., Wolfson D.W., Cho H.C., Husain A., Naqvi N., Chin L.S., Li L., et al. DJ-1 Protects the Heart against Ischemia-Reperfusion Injury by Regulating Mitochondrial Fission. J. Mol. Cell. Cardiol. 2016;97:56&#x2013;66. doi: 10.1016/j.yjmcc.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2016.04.008</ArticleId><ArticleId IdType="pmc">PMC5002379</ArticleId><ArticleId IdType="pubmed">27108530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dongworth R.K., Mukherjee U.A., Hall A.R., Astin R., Ong S.B., Yao Z., Dyson A., Szabadkai G., Davidson S.M., Yellon D.M., et al. DJ-1 Protects against Cell Death Following Acute Cardiac Ischemia-Reperfusion Injury. Cell Death Dis. 2014;5:e1082. doi: 10.1038/cddis.2014.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.41</ArticleId><ArticleId IdType="pmc">PMC3944257</ArticleId><ArticleId IdType="pubmed">24577080</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagisawa D., Kitamura Y., Inden M., Takata K., Taniguchi T., Morikawa S., Morita M., Inubushi T., Tooyama I., Taira T., et al. DJ-1 Protects against Neurodegeneration Caused by Focal Cerebral Ischemia and Reperfusion in Rats. J. Cereb. Blood Flow. Metab. 2008;28:563&#x2013;578. doi: 10.1038/sj.jcbfm.9600553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jcbfm.9600553</ArticleId><ArticleId IdType="pubmed">17882163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N., Wang T., Peng L., Li Y., Zhao Y., Yu S. Attenuation of Inflammation by DJ-1 May Be a Drug Target for Cerebral Ischemia-Reperfusion Injury. Neurochem. Res. 2021;46:1470&#x2013;1479. doi: 10.1007/s11064-021-03288-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-021-03288-z</ArticleId><ArticleId IdType="pubmed">33683631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X.Y., Ren J.M., Liu H.R., Zhou T.T., Wang X.Y., Liu S., Chen H.P. DJ-1 Activates the AMPK/MTOR Pathway by Binding RACK1 to Induce Autophagy and Protect the Myocardium from Ischemia/Hypoxia Injury. Biochem. Biophys. Res. Commun. 2022;637:276&#x2013;285. doi: 10.1016/j.bbrc.2022.10.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.10.100</ArticleId><ArticleId IdType="pubmed">36410277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallinat A., Mendieta G., Vilahur G., Padr&#xf3; T., Badimon L. DJ-1 Administration Exerts Cardioprotection in a Mouse Model of Acute Myocardial Infarction. Front. Pharmacol. 2022;13:1002755. doi: 10.3389/fphar.2022.1002755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1002755</ArticleId><ArticleId IdType="pmc">PMC9539284</ArticleId><ArticleId IdType="pubmed">36210822</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H.H., Xu Q., Chen H.P., Wang S., Huang X.S., Huang Q.R., He M. Stable Overexpression of DJ-1 Protects H9c2 Cells against Oxidative Stress under a Hypoxia Condition. Cell Biochem. Funct. 2013;31:643&#x2013;651. doi: 10.1002/cbf.2949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.2949</ArticleId><ArticleId IdType="pubmed">23281015</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasseur S., Afzal S., Tardivel-Lacombe J., Park D.S., Iovanna J.L., Mak T.W. DJ-1/PARK7 Is an Important Mediator of Hypoxia-Induced Cellular Responses. Proc. Natl. Acad. Sci. USA. 2009;106:1111&#x2013;1116. doi: 10.1073/pnas.0812745106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812745106</ArticleId><ArticleId IdType="pmc">PMC2626605</ArticleId><ArticleId IdType="pubmed">19144925</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsanejad M., Zhang Y., Qu D., Irrcher I., Rousseaux M.W.C., Aleyasin H., Kamkar F., Callaghan S., Slack R.S., Mak T.W., et al. Regulation of the VHL/HIF-1 Pathway by DJ-1. J. Neurosci. 2014;34:8043&#x2013;8050. doi: 10.1523/JNEUROSCI.1244-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1244-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608259</ArticleId><ArticleId IdType="pubmed">24899725</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Zhou C., Lu X., Liu Q., Liu M., Chen G., Chen W., Wang S., Qiu Y. DJ-1 Promotes Survival of Human Colon Cancer Cells under Hypoxia by Modulating HIF-1&#x3b1; Expression through the PI3K-AKT Pathway. Cancer Manag. Res. 2018;10:4615&#x2013;4629. doi: 10.2147/CMAR.S172008.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CMAR.S172008</ArticleId><ArticleId IdType="pmc">PMC6199970</ArticleId><ArticleId IdType="pubmed">30410397</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D., Moreau C., Lassalle P., Perez T., De Seze J., Brunaud-Danel V., Dest&#xe9;e A., Tonnel A.B., Just N. Low Levels of the Vascular Endothelial Growth Factor in CSF from Early ALS Patients. Neurology. 2004;62:2127&#x2013;2129. doi: 10.1212/01.WNL.0000129913.44351.A3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000129913.44351.A3</ArticleId><ArticleId IdType="pubmed">15184633</ArticleId></ArticleIdList></Reference><Reference><Citation>Just N., Moreau C., Lassalle P., Gosset P., Perez T., Brunaud-Danel V., Wallaert B., Dest&#xe9;e A., Defebvre L., Tonnel A.B., et al. High Erythropoietin and Low Vascular Endothelial Growth Factor Levels in Cerebrospinal Fluid from Hypoxemic ALS Patients Suggest an Abnormal Response to Hypoxia. Neuromuscul. Disord. 2007;17:169&#x2013;173. doi: 10.1016/j.nmd.2006.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2006.10.004</ArticleId><ArticleId IdType="pubmed">17142042</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C., Devos D., Brunaud-Danel V., Defebvre L., Perez T., Dest&#xe9;e A., Tonnel A.B., Lassalle P., Just N. Paradoxical Response of VEGF Expression to Hypoxia in CSF of Patients with ALS. J. Neurol. Neurosurg. Psychiatry. 2006;77:255&#x2013;257. doi: 10.1136/jnnp.2005.070904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.070904</ArticleId><ArticleId IdType="pmc">PMC2077591</ArticleId><ArticleId IdType="pubmed">16421133</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C., Gosset P., Kluza J., Brunaud-Danel V., Lassalle P., Marchetti P., Defebvre L., Dest&#xe9;e A., Devos D. Deregulation of the Hypoxia Inducible Factor-1&#x3b1; Pathway in Monocytes from Sporadic Amyotrophic Lateral Sclerosis Patients. Neuroscience. 2011;172:110&#x2013;117. doi: 10.1016/j.neuroscience.2010.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.10.040</ArticleId><ArticleId IdType="pubmed">20977930</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain I.H., Zazzeron L., Goli R., Alexa K., Schatzman-Bone S., Dhillon H., Goldberger O., Peng J., Shalem O., Sanjana N.E., et al. Hypoxia as a Therapy for Mitochondrial Disease. Science. 2016;352:54&#x2013;61. doi: 10.1126/science.aad9642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad9642</ArticleId><ArticleId IdType="pmc">PMC4860742</ArticleId><ArticleId IdType="pubmed">26917594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A.J., Murphy M.P. Selective Targeting of a Redox-Active Ubiquinone to Mitochondria within Cells: Antioxidant and Antiapoptotic Properties. J. Biol. Chem. 2001;276:4588&#x2013;4596. doi: 10.1074/jbc.M009093200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M009093200</ArticleId><ArticleId IdType="pubmed">11092892</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E., Cassina A., Mart&#xed;nez-Palma L., Souza J.M., Bolatto C., Rodr&#xed;guez-Bottero S., Logan A., Smith R.A.J., Murphy M.P., Barbeito L., et al. Neuroprotective Effects of the Mitochondria-Targeted Antioxidant MitoQ in a Model of Inherited Amyotrophic Lateral Sclerosis. Free Radic. Biol. Med. 2014;70:204&#x2013;213. doi: 10.1016/j.freeradbiomed.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.02.019</ArticleId><ArticleId IdType="pubmed">24582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostini F., Masato A., Bubacco L., Bisaglia M. Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges. Int. J. Mol. Sci. 2021;23:398. doi: 10.3390/ijms23010398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010398</ArticleId><ArticleId IdType="pmc">PMC8745385</ArticleId><ArticleId IdType="pubmed">35008822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>